Takeda Pharmaceutical Co (TSE:4502) Tariff Resilience Score: 8/10 (As of Jul. 11, 2026)


TSE:4502 Takeda Pharmaceutical Co Ltd TSE:4502
64 GF Score
Price 円5,359.00
GF Value 円4,536.87
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Takeda Pharmaceutical Co Tariff Resilience Score?

Takeda Pharmaceutical Co TSE:4502 -0.72% 64 Tariff Resilience Score is 8 as of Jul. 11, 2026. GuruFocus rates TSE:4502 with a GF Score™ of 64/100 and a GF Value™ of 円4,536.87 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 1,029 Drug Manufacturers companies, Takeda Pharmaceutical Co ranks better than 99.61% on this metric.

Takeda Pharmaceutical Co has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

Takeda Pharmaceutical Co has Takeda has a diversified global supply chain and significant R&D operations in multiple countries, reducing tariff impact. Pharmaceuticals often have exemptions, and Takeda's strong market presence allows for pricing power.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Takeda Pharmaceutical Co might have Highly Resilient.

Takeda Pharmaceutical Co  (TSE:4502) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Takeda Pharmaceutical Co Tariff Resilience Score Related Terms

TSE:4502 vs ZTS, UTHR: Tariff Resilience Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Takeda Pharmaceutical Co Tariff Resilience Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Tariff Resilience Score falls into.


TSE:4502
64GF Score
Takeda Pharmaceutical Co Ltd TSE:4502
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 8 mean?
Takeda Pharmaceutical Co (TSE:4502) has a Tariff Resilience Score of 8 as of Jul. 11, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Takeda Pharmaceutical Co ranks #4 out of 1029 companies in the Drug Manufacturers industry, placing it in the top 0.40000000000001%.
Is Takeda Pharmaceutical Co's Tariff Resilience Score too high?
Takeda Pharmaceutical Co's current Tariff Resilience Score is 8. Based on the distribution chart, Takeda Pharmaceutical Co ranks #4 out of 1029 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Takeda Pharmaceutical Co has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Takeda Pharmaceutical Co's Tariff Resilience Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Takeda Pharmaceutical Co ranks #4 out of 1029 companies for Tariff Resilience Score. This places Takeda Pharmaceutical Co in the top 0% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Drug Manufacturers company?
A good Tariff Resilience Score depends on the Drug Manufacturers industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Takeda Pharmaceutical Co's current Tariff Resilience Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Takeda Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Takeda Pharmaceutical Co (TSE:4502) is currently considered Modestly Overvalued. The stock's GF Value™ is 円4,536.87, compared to a current price of 円5,359.00 — trading 18.1% above its estimated fair value. The current Tariff Resilience Score is 8. Takeda Pharmaceutical Co's overall GF Score™ is 64/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Takeda Pharmaceutical Co (TSE:4502), the current Tariff Resilience Score is 8 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Takeda Pharmaceutical Co (TSE:4502) Overvalued in 2026?

Based on GuruFocus' analysis, Takeda Pharmaceutical Co stock appears to be overvalued. The current stock price of 円5,359.00 is trading 18.1% above its estimated GF Value™ of 円4,536.87. GuruFocus considers Takeda Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for TSE:4502:

  • Tariff Resilience Score: 8
  • GF Value™: 円4,536.87 vs. price of 円5,359.00 (18.1% above fair value)
  • GF Score™: 64/100 with 9 warning signs

No single metric tells the full story. See the TSE:4502 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Takeda Pharmaceutical Co Business Description

Address 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
64GF Score

Get the complete analysis for TSE:4502

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円5,359.00
Price
円4,536.87
GF Value